Kirby McInerney LLP is investigating potential claims against Gentiva Health Services, Inc. (“Gentiva” or the “Company”) (NASDAQ: GTIV) concerning the proposed acquisition of the Company by Kindred Healthcare, Inc. (“Kindred”) (NYSE: KND). Under the terms of the definitive agreement, Gentiva stockholders will receive $14.50 in cash and 0.257 shares of Kindred common stock for each share of Gentiva common stock they own, valuing the deal at approximately $19.50 per share. The total transaction value is approximately $1.8 billion.

The investigation concerns whether the Gentiva Board of Directors violated its fiduciary duties by agreeing to the proposed transaction and whether the proposed consideration adequately values the Company’s common stock.

If you are a Gentiva stockholder and wish to obtain additional information, please contact J. Brandon Walker, Esq. by email at bwalker@kmllp.com, or telephone at (212) 699-1145, Melissa Fortunato, Esq. by email at mfortunato@kmllp.com, or telephone at (212) 699-1141, or toll free at (888) 529-4787, or by filling out this contact form. There is no cost or obligation to you.

Kirby McInerney LLP is a New York-based law firm concentrating in securities, whistleblower, antitrust and consumer litigation. For additional information, please go to www.kmllp.com.

Copyright Business Wire 2010